SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 5.5 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS

被引：0
|
作者：
Genovese, M. C. [1 ]
Smolen, J. S. [2 ]
Takeuchi, T. [3 ]
Hyslop, D. [4 ]
Macias, W. L. [4 ]
Rooney, T. P. [4 ]
Chen, L. [4 ]
Dickson, C. L. [4 ]
Camp, J. R. [4 ]
Cardillo, T. E. [4 ]
Ishii, T. [5 ]
Winthrop, K. L. [6 ]
Garcia, E. G. [4 ]
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Med Univ Vienna, Vienna, Austria
[3] Keio Univ, Tokyo, Japan
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Kobe, Hyogo, Japan
[6] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
375
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [41] SAFETY PROFILE OF UPADACITINIB UP TO 6.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Cohen, S. B.
    Van Vollenhoven, R.
    Curtis, J.
    Calabrese, L.
    Zerbini, C.
    Tanaka, Y.
    Bessette, L.
    Richez, C.
    Strengholt, S.
    Coombs, D.
    Khan, N.
    Gara, A.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 709 - 710
  • [42] Safety of Baricitinib 4 mg for the Treatment of Moderate to Severe Rheumatoid Arthritis
    Dabal, Tracey D.
    Haltom, Matthew B.
    Patel, Puja P.
    Son, Christine K.
    Joglekar, Kiran P.
    Groeschell, Charles M.
    Chumpia, Mason M.
    Kamal, Sehrish F.
    Seth, Ankur
    Jackson, Christopher D.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (05) : 288 - 292
  • [43] Safety of Baricitinib for the Treatment of Atopic Dermatitis up to 3.9 Years Treatment: An Update Integrated Analysis of 8 Clinical Trials
    Bieber, Thomas
    Katoh, Norito
    Simpson, Eric L.
    de Bruin-Weller, Marjolein S.
    Thaci, Diamant
    Torrelo, Antonio
    Sontag, Angelina
    Grond, Susanne
    Issa, Maher
    Lu, Xiaoyu
    Cardillo, Tracy
    Holzwarth, Katrin
    Thyssen, Jacob P.
    Boecker, Ulrike
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 90 - 91
  • [44] SAFETY PROFILE OF BARICITINIB IN PATIENTS WITH ACTIVE RA: AN INTEGRATED ANALYSIS
    Smolen, J.
    Genovese, M.
    Takeuchi, T.
    Hyslop, D.
    Macias, W. L.
    Rooney, T. P.
    Chen, L.
    Dickson, C.
    Riddle, J.
    Cardillo, T.
    Winthrop, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 243 - 244
  • [45] Analysis of the effectiveness, safety and predictors of good response of baricitinib in Rheumatoid Arthritis
    Ramirez de la Torre, M.
    Andreu Ubero, J. M.
    Nucete Gallego, B.
    Caliz Caliz, R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 280 - 281
  • [46] Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database
    Taylor, Peter C.
    Takeuchi, Tsutomu
    Burmester, Gerd R.
    Durez, Patrick
    Smolen, Josef S.
    Deberdt, Walter
    Issa, Maher
    Terres, Jorge Ross
    Bello, Natalia
    Winthrop, Kevin L.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 335 - 343
  • [47] Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
    Burmester, Gerd R.
    Gottenberg, Jacques-Eric
    Caporali, Roberto
    Winthrop, Kevin L.
    Tanaka, Yoshiya
    Omoruyi, Edmund V. Ekoka
    Rajendran, Vijay
    Van Hoek, Paul
    Van Beneden, Katrien
    Takeuchi, Tsutomu
    Westhovens, Rene
    Aletaha, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (09) : 1110 - 1117
  • [48] Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up
    Fleischmann, Roy
    Genovese, Mark C.
    Lin, Yong
    St John, Gregory
    van der Heijde, Desiree
    Wang, Sheldon
    Jose Gomez-Reino, Juan
    Antonio Maldonado-Cocco, Jose
    Stanislav, Marina
    Kivitz, Alan J.
    Burmester, Gerd R.
    RHEUMATOLOGY, 2020, 59 (02) : 292 - 302
  • [49] Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis
    Morand, Eric
    Smolen, Josef S.
    Petri, Michelle
    Tanaka, Yoshiya
    Silk, Maria
    Dickson, Christina
    Meszaros, Gabriella
    de la Torre, Inmaculada
    Issa, Maher
    Zhang, Hong
    Doerner, Thomas
    RMD OPEN, 2023, 9 (03):
  • [50] Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment (vol 46, pg 7, 2019)
    Smolen, J. S.
    Genovese, M. C.
    Takeuchi, T.
    Hyslop, D. L.
    Macias, W. L.
    Rooney, T.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (12) : 1648 - 1649
12345